Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christina Cho

Showing results (31-40 of 99) with videos related to

Pageof 10
Sort By:
Transplant Infectious Disease : an Official Journal of the Transplantation Society|April 19, 2018
Sequential systematic anti-mold prophylaxis with micafungin and voriconazole results in very low incidence of invasive mold infections in patients undergoing allogeneic hematopoietic stem cell transplantationClaudia Rosillo, Ana Maria Avila, Yao-Ting Huang, et al.
Oncogene|August 19, 2020
Cancer-associated fibroblasts downregulate type I interferon receptor to stimulate intratumoral stromagenesisChristina Cho, Riddhita Mukherjee, Amy R Peck, et al.
Biomedicines|August 28, 2025
Curative Therapies for Hemophilias and Hemoglobinopathies in Adults: Immune, Gene, and Stem Cell Approaches in a Global ContextAyrton Bangolo, Behzad Amoozgar, Lili Zhang, et al.
Transplantation and Cellular Therapy|May 24, 2021
Oral Proteasome Inhibitor Ixazomib for Switch-Maintenance Prophylaxis of Recurrent or Late Acute and Chronic Graft-versus-Host Disease after Day 100 in Allogeneic Stem Cell TransplantationNatasia Rodriguez, Jasme Lee, Lisa Flynn, et al.
Bone Marrow Transplantation|February 13, 2024
Immune reconstitution, vaccine responses, and rituximab use after ex-vivo CD34-selected myeloablative allogenic hematopoietic cell transplantationGiovanna Melica, Elaina Preston, Meighan Palazzo, et al.
Cancer Immunology, Immunotherapy : CII|September 5, 2022
Induction of the activating transcription factor-4 in the intratumoral CD8+ T cells sustains their viability and anti-tumor activitiesZhen Lu, Eun-Ah Bae, Ioannis I Verginadis, et al.
Transplantation and Cellular Therapy|September 22, 2021
Hypomethylating Agents and FLT3 Inhibitors As Maintenance Treatment for Acute Myeloid Leukemia and Myelodysplastic Syndrome After Allogeneic Hematopoietic Stem Cell Transplantation-A Systematic Review and Meta-AnalysisJan Philipp Bewersdorf, Cecily Allen, Abu-Sayeef Mirza, et al.
Development (Cambridge, England)|March 7, 2013
Progesterone drives mammary secretory differentiation via RankL-mediated induction of Elf5 in luminal progenitor cellsHeather J Lee, David Gallego-Ortega, Anita Ledger, et al.
Transplantation and Cellular Therapy|May 15, 2021
Universal Engraftment after Allogeneic Hematopoietic Cell Transplantation Using Cryopreserved CD34-Selected GraftsReuben P Jacob, Jessica Flynn, Sean M Devlin, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 3, 2022
Impact of Letermovir Primary Cytomegalovirus Prophylaxis on 1-Year Mortality After Allogeneic Hematopoietic Cell Transplantation: A Retrospective Cohort StudyYiqi Su, Anat Stern, Eleni Karantoni, et al.
Pageof 10

Showing results (31-40 of 99) with videos related to

Sort By:
Pageof 10
Transplant Infectious Disease : an Official Journal of the Transplantation Society|April 19, 2018
Sequential systematic anti-mold prophylaxis with micafungin and voriconazole results in very low incidence of invasive mold infections in patients undergoing allogeneic hematopoietic stem cell transplantationClaudia Rosillo, Ana Maria Avila, Yao-Ting Huang, et al.
Oncogene|August 19, 2020
Cancer-associated fibroblasts downregulate type I interferon receptor to stimulate intratumoral stromagenesisChristina Cho, Riddhita Mukherjee, Amy R Peck, et al.
Biomedicines|August 28, 2025
Curative Therapies for Hemophilias and Hemoglobinopathies in Adults: Immune, Gene, and Stem Cell Approaches in a Global ContextAyrton Bangolo, Behzad Amoozgar, Lili Zhang, et al.
Transplantation and Cellular Therapy|May 24, 2021
Oral Proteasome Inhibitor Ixazomib for Switch-Maintenance Prophylaxis of Recurrent or Late Acute and Chronic Graft-versus-Host Disease after Day 100 in Allogeneic Stem Cell TransplantationNatasia Rodriguez, Jasme Lee, Lisa Flynn, et al.
Bone Marrow Transplantation|February 13, 2024
Immune reconstitution, vaccine responses, and rituximab use after ex-vivo CD34-selected myeloablative allogenic hematopoietic cell transplantationGiovanna Melica, Elaina Preston, Meighan Palazzo, et al.
Cancer Immunology, Immunotherapy : CII|September 5, 2022
Induction of the activating transcription factor-4 in the intratumoral CD8+ T cells sustains their viability and anti-tumor activitiesZhen Lu, Eun-Ah Bae, Ioannis I Verginadis, et al.
Transplantation and Cellular Therapy|September 22, 2021
Hypomethylating Agents and FLT3 Inhibitors As Maintenance Treatment for Acute Myeloid Leukemia and Myelodysplastic Syndrome After Allogeneic Hematopoietic Stem Cell Transplantation-A Systematic Review and Meta-AnalysisJan Philipp Bewersdorf, Cecily Allen, Abu-Sayeef Mirza, et al.
Development (Cambridge, England)|March 7, 2013
Progesterone drives mammary secretory differentiation via RankL-mediated induction of Elf5 in luminal progenitor cellsHeather J Lee, David Gallego-Ortega, Anita Ledger, et al.
Transplantation and Cellular Therapy|May 15, 2021
Universal Engraftment after Allogeneic Hematopoietic Cell Transplantation Using Cryopreserved CD34-Selected GraftsReuben P Jacob, Jessica Flynn, Sean M Devlin, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 3, 2022
Impact of Letermovir Primary Cytomegalovirus Prophylaxis on 1-Year Mortality After Allogeneic Hematopoietic Cell Transplantation: A Retrospective Cohort StudyYiqi Su, Anat Stern, Eleni Karantoni, et al.
Pageof 10